首页> 外国专利> DIABETIC NEPHROPATHY EARLY DETECTION REAGENT KIT, BIOMARKER TESTING METHOD AND APPLICATIONS

DIABETIC NEPHROPATHY EARLY DETECTION REAGENT KIT, BIOMARKER TESTING METHOD AND APPLICATIONS

机译:糖尿病肾病早期检测试剂盒,生物标志物检测方法及应用

摘要

A diabetic nephropathy early detection reagent kit comprising testing reagents. The testing reagents comprise either two or three among a first testing reagent, a second testing reagent, a third testing reagent, and a fourth testing reagent. A solute for the first testing reagent is a first podocalyxin antibody. A solute for the second testing reagent is a first collagen IV antibody. A solute for the third testing reagent is a first liver fatty acid binding protein antibody. A solute for the fourth testing reagent is a first neutrophil gelatinase-associated lipocalin antibody. By having either two or three among podocalyxin, collagen IV, liver fatty acid binding protein, and neutrophil gelatinase-associated lipocalin serving as biomarkers, the diabetic nephropathy early screening reagent kit is capable of providing assistance in determining kidney damages on the basis of an actual testing result, thus providing assistance in distinguishing early-stage diabetic nephropathy.
机译:包含测试试剂的糖尿病肾病早期检测试剂盒。测试试剂包括第一测试试剂,第二测试试剂,第三测试试剂和第四测试试剂中的两种或三种。第一测试试剂的溶质是第一podocalyxin抗体。第二测试试剂的溶质是第一胶原IV抗体。第三测试试剂的溶质是第一肝脂肪酸结合蛋白抗体。第四测试试剂的溶质是第一中性粒细胞明胶酶相关的脂环蛋白抗体。糖尿病肾病早期筛查试剂盒通过将足浴毒素,胶原蛋白IV,肝脂肪酸结合蛋白和中性粒细胞明胶酶相关的脂钙素中的两种或三种用作生物标记物,能够根据实际情况帮助确定肾脏损害检测结果,从而有助于区分早期糖尿病肾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号